Abbott Laboratories (ABT) Earnings Date, Estimates & Call Transcripts $117.82 +1.77 (+1.53%) (As of 10/16/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryLatest Earnings DateOct. 16ConfirmedActual EPS (Oct. 16) $1.21 Beat By $0.01 Consensus EPS (Oct. 16) $1.20 Conference Call TranscriptConference Call AudioEarnings Press ReleaseEarnings Slide Deck Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueABT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ABT Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Porter & CompanyElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump. Watch this new documentary and you’ll discover what Elon knows, Abbott Laboratories Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20242$0.96$1.03$1.00 Q2 20242$1.10$1.13$1.121.080 - 1.120Q3 20242$1.18$1.19$1.191.180 - 1.220Q4 20242$1.23$1.34$1.291.310 - 1.370FY 20248$4.47$4.69$4.58 Q1 20252$1.13$1.26$1.20 Q2 20252$1.26$1.28$1.27 Q3 20252$1.24$1.31$1.28 Q4 20251$1.42$1.42$1.42 FY 20257$5.05$5.27 $5.16ABT Earnings Date and InformationAbbott Laboratories last announced its earnings results on October 16th, 2024. The healthcare product maker reported $1.21 earnings per share for the quarter, topping the consensus estimate of $1.20 by $0.01. The business had revenue of $10.64 billion for the quarter, compared to the consensus estimate of $10.55 billion. Its quarterly revenue was up 4.9% on a year-over-year basis. Abbott Laboratories has generated $3.21 earnings per share over the last year ($3.21 diluted earnings per share) and currently has a price-to-earnings ratio of 37.2. Earnings for Abbott Laboratories are expected to grow by 10.09% in the coming year, from $4.66 to $5.13 per share. Abbott Laboratories has confirmed that its next quarterly earnings report will be published on Wednesday, October 16th, 2024. Read More Abbott Laboratories Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks10/16/2024-$1.20$1.21+$0.01-$10.55 billion$10.64 billion 7/18/2024Q2 2024$1.10$1.14+$0.04$1.54$10.37 billion$10.38 billion 4/17/2024Q1 2024$0.96$0.98+$0.02$1.26$9.88 billion$9.96 billion 1/24/2024Q4 2023$1.19$1.19-$1.47$10.19 billion$10.24 billion 10/18/2023Q3 2023$1.10$1.14+$0.04$1.46$9.82 billion$10.14 billion 7/20/2023Q2 2023$1.05$1.08+$0.03$1.38$9.71 billion$9.98 billion Get 3 actionable trade entries + profit targets & stop losses! (Ad)I’ve boiled down my 40 years of trading experience into a state-of-the-art breakthrough designed to help pick trades FOR YOU… COMPLETELY. AUTOMATED. Naturally, there were smaller wins and those that did not work out. And we cannot promise future returns or against losses… But if you join me at my live, FREE briefing just before the market closes on Thursday, October 17th @ 3pm ET…Sign up for the broadcast here4/19/2023Q1 2023$0.98$1.03+$0.05$1.31$9.64 billion$9.75 billion 1/25/2023Q4 2022$0.90$1.03+$0.13$1.47$9.69 billion$10.09 billion 10/19/2022Q3 2022$0.90$1.15+$0.25$1.49$9.65 billion$10.41 billion 7/20/2022Q2 2022$1.09$1.43+$0.34$1.72$10.37 billion$11.26 billion 4/20/2022Q1 2022$1.47$1.73+$0.26$2.09$11.00 billion$11.90 billion 1/26/2022Q4 2021$1.18$1.32+$0.14$1.53$10.71 billion$11.47 billion 10/19/2021Q3 2021$0.94$1.40+$0.46$1.63$9.56 billion$10.93 billion 7/21/2021Q2 2021$1.02$1.17+$0.15$1.68$9.67 billion$10.22 billion 4/19/2021Q1 2021$1.27$1.32+$0.05$1.64$10.72 billion$10.45 billion 1/26/2021Q4 2020$1.35$1.45+$0.10$1.70$9.94 billion$10.70 billion 10/21/2020Q3 2020$0.90$0.98+$0.08$1.27$8.53 billion$8.85 billion 7/16/2020Q2 2020$0.42$0.57+$0.15$0.84$6.85 billion$7.33 billion 4/16/2020Q1 2020$0.58$0.65+$0.07$0.99$7.47 billion$7.73 billion 1/22/2020Q4 2019$0.95$0.95-$1.31$8.26 billion$8.31 billion 10/16/2019Q3 2019$0.84$0.84-$1.15$8.10 billion$8.08 billion Abbott Laboratories Earnings - Frequently Asked Questions When is Abbott Laboratories's earnings date? Abbott Laboratories has confirmed that its next quarterly earnings data will be published on Wednesday, October 16th, 2024. Learn more on ABT's earnings history. What guidance has Abbott Laboratories issued on next quarter's earnings? Abbott Laboratories issued an update on its FY 2024 earnings guidance on Wednesday, October, 16th. The company provided EPS guidance of 4.640-4.700 for the period, compared to the consensus EPS estimate of 4.660. The company issued revenue guidance of -. Did Abbott Laboratories beat their earnings estimates last quarter? In the previous quarter, Abbott Laboratories (NYSE:ABT) reported $1.21 earnings per share (EPS) to beat the analysts' consensus estimate of $1.20 by $0.01. Learn more on analysts' earnings estimate vs. ABT's actual earnings. How can I listen to Abbott Laboratories's earnings conference call? The conference call for Abbott Laboratories's latest earnings report can be listened to online. Listen to Conference Call How can I read Abbott Laboratories's conference call transcript? The conference call transcript for Abbott Laboratories's latest earnings report can be read online. Read Transcript How much revenue does Abbott Laboratories generate each year? Abbott Laboratories (NYSE:ABT) has a recorded annual revenue of $40.73 billion. How much profit does Abbott Laboratories generate each year? Abbott Laboratories (NYSE:ABT) has a recorded net income of $5.72 billion. ABT has generated $3.21 earnings per share over the last four quarters. What is Abbott Laboratories's price-to-earnings ratio? Abbott Laboratories (NYSE:ABT) has a trailing price-to-earnings ratio of 37.17 and a forward price-to-earnings ratio of 25.28. The price/earnings-to-growth ratio is 2.74. What is Abbott Laboratories's EPS forecast for next year? Abbott Laboratories's earnings are expected to grow from $4.66 per share to $5.13 per share in the next year, which is a 10.09% increase. More Earnings Resources from MarketBeat Related Companies: ISRG Earnings SYK Earnings BSX Earnings MDT Earnings BDX Earnings EW Earnings IDXX Earnings RMD Earnings DXCM Earnings BIIB Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles: Bank of America Earnings Uncover Shifts in Consumer SpendingGoldman Sachs Earnings Reveal Market Moves Investors Can't IgnoreNike’s Post-Earnings Drop Presents a Buying OpportunityMicron Stock Soars as AI Demand Fuels Big Q4 Earnings BeatGameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 Earnings This page (NYSE:ABT) was last updated on 10/16/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsThe stock market collapsed and didn't recover for an entire decade. And what we're facing today could be ev...Behind the Markets | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | SponsoredI’m going on record with my Trump predictionI’m urging my readers to take this forecast seriously and get ready to take advantage of this generational wea...Manward Press | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Abbott Laboratories You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Abbott Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ABT Stock Alerts